InDex Pharmaceuticals Holding AB
| Position | Amount | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2021-02-08 | InDex Pharmaceuticals Holding AB | Peter Zerhouni | Chief Executive Officer (CEO)/Managing Directory | Subscription | 550 000 | 1,2 | SEK | 660 000 | 2021-02-04 |
| 2021-02-08 | InDex Pharmaceuticals Holding AB | Peter Zerhouni | Chief Executive Officer (CEO)/Managing Directory | Exercise decrease | 550 000 | 0 | SEK | 0 | 2021-02-04 |
| 2021-02-09 | InDex Pharmaceuticals Holding AB | Wenche Nelly Albertine Rolfsen Sandsborg | Chairman of the Board of Directors | Exercise decrease | 94 500 | 0 | SEK | 0 | 2021-02-04 |
| 2021-02-09 | InDex Pharmaceuticals Holding AB | Rolfsen Consulting AB | Chairman of the Board of Directors | Exercise decrease | 406 120 | 0 | SEK | 0 | 2021-02-04 |
| 2021-02-10 | InDex Pharmaceuticals Holding AB | Stig Pedersen | Member of the Board of Directors | Exercise decrease | 319 810 | 0 | SEK | 0 | 2021-02-08 |
| 2021-02-10 | InDex Pharmaceuticals Holding AB | Stig Pedersen | Member of the Board of Directors | Subscription | 319 810 | 1,2 | SEK | 383 772 | 2021-02-08 |
| 2021-02-10 | InDex Pharmaceuticals Holding AB | Uli Hacksell | Member of the Board of Directors | Subscription | 340 000 | 1,2 | SEK | 408 000 | 2021-02-08 |
| 2021-07-06 | InDex Pharmaceuticals Holding AB | Johan Giléus | Chief Financial Officer (CFO) | Allotment | 772 300 | 0 | SEK | 0 | 2021-07-05 |
| 2021-07-06 | InDex Pharmaceuticals Holding AB | Peter Zerhouni | Chief Executive Officer (CEO)/Managing Directory | Allotment | 1 930 700 | 0 | SEK | 0 | 2021-07-05 |
| 2021-07-07 | InDex Pharmaceuticals Holding AB | Pernilla Sandwall | Other member of the company's administrative, management or supervisory body | Allotment | 772 300 | 0 | SEK | 0 | 2021-07-05 |
| 2023-02-23 | InDex Pharmaceuticals Holding AB | Wenche Nelly Albertine Rolfsen Sandsborg | Chairman of the Board of Directors | Acquisition | 155 000 | 0,42 | SEK | 65 100 | 2023-02-22 |
| 2023-02-24 | InDex Pharmaceuticals Holding AB | Jenny Sundqvist | Chief Executive Officer (CEO)/Managing Directory | Acquisition | 121 951 | 0,41 | SEK | 49 999,91 | 2023-02-22 |
| 2023-02-24 | InDex Pharmaceuticals Holding AB | Johan Giléus | Deputy CEO/Deputy Managing Director, Chief Financial Officer (CFO) | Acquisition | 150 000 | 0,44 | SEK | 66 000 | 2023-02-23 |
| 2023-07-14 | InDex Pharmaceuticals Holding AB | Johan Giléus | Deputy CEO/Deputy Managing Director, Chief Financial Officer (CFO) | Allotment | 772 300 | 0 | SEK | 0 | 2023-07-11 |
| 2023-07-14 | InDex Pharmaceuticals Holding AB | Jenny Sundqvist | Chief Executive Officer (CEO)/Managing Directory | Allotment | 1 930 700 | 0 | SEK | 0 | 2023-07-11 |
| 2024-06-14 | InDex Pharmaceuticals Holding AB | Cecilia Schéele | Chief Financial Officer (CFO) | Pledging | 4 046 462 | 0 | SEK | 0 | 2024-06-13 |
| 2024-06-14 | InDex Pharmaceuticals Holding AB | Cecilia Schéele | Chief Financial Officer (CFO) | Subscription | 4 046 462 | 0,506 | SEK | 2 047 509,772 | 2024-06-13 |
| 2024-06-14 | InDex Pharmaceuticals Holding AB | Mark Quick | Other member of the company's administrative, management or supervisory body | Subscription | 40 464 624 | 0,506 | SEK | 20 475 099,744 | 2024-06-13 |
| 2024-06-14 | InDex Pharmaceuticals Holding AB | Cecilia Edström | Member of the Board of Directors | Acquisition | 11 650 000 | 0,067 | SEK | 780 550 | 2024-06-13 |
| 2024-06-14 | InDex Pharmaceuticals Holding AB | Cecilia Edström | Member of the Board of Directors | Subscription | 2 697 642 | 0,506 | SEK | 1 365 006,852 | 2024-06-13 |